Infinity Pharmaceuticals Inc
OTC:INFIQ

Watchlist Manager

Infinity Pharmaceuticals Inc

OTC:INFIQ

Watchlist

Dividends

Price: 0.0001 USD Market Closed

Market Cap: 91 USD

Have any thoughts about
Infinity Pharmaceuticals Inc?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Fubotv Inc NYSE:FUBO	Media
US	Bank of America Corp NYSE:BAC	Banking
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Uber Technologies Inc NYSE:UBER	Road & Rail
CN	NIO Inc NYSE:NIO	Automobiles
US	Fluor Corp NYSE:FLR	Construction
US	Jacobs Engineering Group Inc NYSE:J	Professional Services
US	TopBuild Corp NYSE:BLD	Consumer products
US	Abbott Laboratories NYSE:ABT	Health Care
US	Chevron Corp NYSE:CVX	Energy
US	Occidental Petroleum Corp NYSE:OXY	Energy
US	Matrix Service Co NASDAQ:MTRX	Construction
US	Automatic Data Processing Inc NASDAQ:ADP	Technology
US	Qualcomm Inc NASDAQ:QCOM	Semiconductors
US	PayPal Holdings Inc NASDAQ:PYPL	Technology
US	Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 0.0001 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

INFIQ Alert

Infinity Pharmaceuticals Inc

0.0001

0.0000 (0%)

52 Week Range	0.0001 0.006
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	PayPal Holdings Inc NASDAQ:PYPL	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Infinity Pharmaceuticals Inc

What unique competitive advantages
does Infinity Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does Infinity Pharmaceuticals Inc face in the near future?

Provide an overview of the primary business activities
of Infinity Pharmaceuticals Inc.

What are the Revenue projections
for Infinity Pharmaceuticals Inc?

Provide an overview of the primary business activities
of Infinity Pharmaceuticals Inc.

What unique competitive advantages
does Infinity Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does Infinity Pharmaceuticals Inc face in the near future?

Summarize the latest earnings call
of Infinity Pharmaceuticals Inc.

Show all valuation multiples
for Infinity Pharmaceuticals Inc.

Provide P/S
for Infinity Pharmaceuticals Inc.

Provide P/E
for Infinity Pharmaceuticals Inc.

Provide P/OCF
for Infinity Pharmaceuticals Inc.

Provide P/FCFE
for Infinity Pharmaceuticals Inc.

Provide P/B
for Infinity Pharmaceuticals Inc.

Provide EV/S
for Infinity Pharmaceuticals Inc.

Provide EV/GP
for Infinity Pharmaceuticals Inc.

Provide EV/EBITDA
for Infinity Pharmaceuticals Inc.

Provide EV/EBIT
for Infinity Pharmaceuticals Inc.

Provide EV/OCF
for Infinity Pharmaceuticals Inc.

Provide EV/FCFF
for Infinity Pharmaceuticals Inc.

Provide EV/IC
for Infinity Pharmaceuticals Inc.

What are the Revenue projections
for Infinity Pharmaceuticals Inc?

How accurate were the past Revenue estimates
for Infinity Pharmaceuticals Inc?

What are the Net Income projections
for Infinity Pharmaceuticals Inc?

How accurate were the past Net Income estimates
for Infinity Pharmaceuticals Inc?

What are the EPS projections
for Infinity Pharmaceuticals Inc?

How accurate were the past EPS estimates
for Infinity Pharmaceuticals Inc?

What are the EBIT projections
for Infinity Pharmaceuticals Inc?

How accurate were the past EBIT estimates
for Infinity Pharmaceuticals Inc?

Compare the revenue forecasts
for Infinity Pharmaceuticals Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Infinity Pharmaceuticals Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Infinity Pharmaceuticals Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Infinity Pharmaceuticals Inc compared to its peers.

Compare the P/E ratios
of Infinity Pharmaceuticals Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Infinity Pharmaceuticals Inc with its peers.

Analyze the financial leverage
of Infinity Pharmaceuticals Inc compared to its main competitors.

Show all profitability ratios
for Infinity Pharmaceuticals Inc.

Provide ROE
for Infinity Pharmaceuticals Inc.

Provide ROA
for Infinity Pharmaceuticals Inc.

Provide ROIC
for Infinity Pharmaceuticals Inc.

Provide ROCE
for Infinity Pharmaceuticals Inc.

Provide Gross Margin
for Infinity Pharmaceuticals Inc.

Provide Operating Margin
for Infinity Pharmaceuticals Inc.

Provide Net Margin
for Infinity Pharmaceuticals Inc.

Provide FCF Margin
for Infinity Pharmaceuticals Inc.

Show all solvency ratios
for Infinity Pharmaceuticals Inc.

Provide D/E Ratio
for Infinity Pharmaceuticals Inc.

Provide D/A Ratio
for Infinity Pharmaceuticals Inc.

Provide Interest Coverage Ratio
for Infinity Pharmaceuticals Inc.

Provide Altman Z-Score Ratio
for Infinity Pharmaceuticals Inc.

Provide Quick Ratio
for Infinity Pharmaceuticals Inc.

Provide Current Ratio
for Infinity Pharmaceuticals Inc.

Provide Cash Ratio
for Infinity Pharmaceuticals Inc.

What is the historical Revenue growth
over the last 5 years for Infinity Pharmaceuticals Inc?

What is the historical Net Income growth
over the last 5 years for Infinity Pharmaceuticals Inc?

What is the current Free Cash Flow
of Infinity Pharmaceuticals Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Infinity Pharmaceuticals Inc.

INFIQ

Income Statement

Net Income (Common)

Infinity Pharmaceuticals Inc
Net Income (Common)

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Infinity Pharmaceuticals Inc
Net Income (Common) Peer Comparison

Comparables:

ABBV

GILD

AMGN

VRTX

REGN

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

	Net Income (Common)	CAGR 3Y	CAGR 5Y	CAGR 10Y
Infinity Pharmaceuticals Inc OTC:INFIQ	Net Income (Common) -$40.9m	CAGR 3-Years 2%	CAGR 5-Years -6%	CAGR 10-Years 7%
Abbvie Inc NYSE:ABBV	Net Income (Common) $5.3B	CAGR 3-Years -7%	CAGR 5-Years 5%	CAGR 10-Years 2%
Gilead Sciences Inc NASDAQ:GILD	Net Income (Common) $1.1B	CAGR 3-Years -41%	CAGR 5-Years -29%	CAGR 10-Years -18%
Amgen Inc NASDAQ:AMGN	Net Income (Common) $3.1B	CAGR 3-Years -18%	CAGR 5-Years -17%	CAGR 10-Years -5%
Vertex Pharmaceuticals Inc NASDAQ:VRTX	Net Income (Common) -$489.9m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years 0%
Regeneron Pharmaceuticals Inc NASDAQ:REGN	Net Income (Common) $4.3B	CAGR 3-Years -11%	CAGR 5-Years 16%	CAGR 10-Years 27%

What is Infinity Pharmaceuticals Inc's Net Income (Common)?

Net Income (Common)
-40.9m USD

Based on the financial report for Jun 30, 2023, Infinity Pharmaceuticals Inc's Net Income (Common) amounts to -40.9m USD.

What is Infinity Pharmaceuticals Inc's Net Income (Common) growth rate?

Net Income (Common) CAGR 10Y
7%

Over the last year, the Net Income (Common) growth was 13%. The average annual Net Income (Common) growth rates for Infinity Pharmaceuticals Inc have been 2% over the past three years , -6% over the past five years , and 7% over the past ten years .

Infinity Pharmaceuticals Inc
OTC:INFIQ

Infinity Pharmaceuticals Inc
Net Income (Common)

Infinity Pharmaceuticals Inc
Net Income (Common) Peer Comparison

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

See Also

What is Infinity Pharmaceuticals Inc's Net Income (Common)?

Net Income (Common)
-40.9m USD

What is Infinity Pharmaceuticals Inc's Net Income (Common) growth rate?

Net Income (Common) CAGR 10Y
7%

Company

Help

Tools

Stocks

Infinity Pharmaceuticals Inc OTC:INFIQ

Infinity Pharmaceuticals Inc Net Income (Common)

Infinity Pharmaceuticals Inc Net Income (Common) Peer Comparison

Competitive Net Income (Common) Analysis Latest Figures & CAGR of Competitors

See Also

What is Infinity Pharmaceuticals Inc's Net Income (Common)? Net Income (Common) -40.9m USD

What is Infinity Pharmaceuticals Inc's Net Income (Common) growth rate? Net Income (Common) CAGR 10Y 7%

Company

Help

Tools

Stocks

Infinity Pharmaceuticals Inc
OTC:INFIQ

Infinity Pharmaceuticals Inc
Net Income (Common)

Infinity Pharmaceuticals Inc
Net Income (Common) Peer Comparison

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

What is Infinity Pharmaceuticals Inc's Net Income (Common)?

Net Income (Common)
-40.9m USD

What is Infinity Pharmaceuticals Inc's Net Income (Common) growth rate?

Net Income (Common) CAGR 10Y
7%